Table 3.
Comprehensive Metabolic Panel with Hepatic Function
| Placebo | Hyaluronan | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Test | Gender | Unit | Min | Max | Week 0 | Week 2 | Week 4 | Week 0 | Week 2 | Week 4 |
| BUN | Male | mg/dL | 6 | 20 | 15.00±3.35 | 14.91±3.30 | 14.45±3.33 | 17.36±5.18 | 17.43±3.88 | 15.00±4.15 |
| Female | mg/dL | 6 | 20 | 15.33±4.43 | 14.04±4.39 | 14.17±4.26 | 13.96±5.17 | 13.43±2.97 | 12.33±3.58 | |
| Creatinine | Male | mg/dL | 0.6 | 1.3 | 0.90±0.13 | 0.85±0.11 | 0.86±0.10 | 0.96±0.08 | 0.92±0.09 | 0.91±0.09 |
| Female | mg/dL | 0.6 | 1.3 | 0.74±0.12 | 0.73±0.11 | 0.73±0.11 | 0.73±0.08 | 0.70±0.08 | 0.69±0.10 | |
| GFR | Male | mL/min/1.7>60 | na | >60 | >60 >60 | >60 >60 | >60 >60 | >60 >60 | >60 >60 | >60 |
| Female | mL/min/1.7>60 | na | >60 | >60 >60 | >60 >60 | >60 >60 | >60 >60 | >60 >60 | >60 | |
| Bun-Creat. | Male | Ratio | 12 | 20 | 17.00±4.73 | 17.69±3.86 | 16.85±4.00 | 18.18±5.37 | 19.16±4.42 | 16.58±4.82 |
| Female | Ratio | 12 | 20 | 21.45±8.09 | 19.37±5.99 | 19.87±7.02 | 18.97±6.52 | 19.39±4.87 | 17.83±4.23 | |
| Glucose | Male | mg/dL | 74 | 106 | 88.27±9.63 | 88.45±11.31 | 90.55±6.70 | 91.50±17.63 | 93.57±18.14 | 91.79±14.57 |
| Female | mg/dL | 74 | 106 | 93.38±26.66 | 90.96±11.78 | 91.04±19.13 | 89.52±14.06 | 88.83±10.32 | 89.43±13.87 | |
| Total protein | Male | g/dL | 6.5 | 8.2 | 7.07±0.43 | 6.84±0.42 | 6.79±0.34 | 6.94±0.44 | 6.88±0.35 | 6.78±0.31 |
| Female | g/dL | 6.5 | 8.2 | 6.83±0.34 | 6.92±0.38 | 6.87±0.39 | 6.83±0.56 | 6.82±0.32 | 6.76±0.37 | |
| Albumin | Male | g/dL | 3.5 | 5 | 4.08±0.21 | 3.98±0.17 | 4.02±0.26 | 4.19±0.31 | 4.18±0.30 | 4.04±0.25 |
| Female | g/dL | 3.5 | 5 | 3.89±0.25 | 3.87±0.27 | 3.87±0.27 | 3.86±0.31 | 3.89±0.36 | 3.84±0.27 | |
| A/G ratio | Male | Ratio | 1.2 | 2.2 | 1.38±0.16 | 1.42±0.17 | 1.48±0.29 | 1.54±0.19 | 1.54±0.18 | 1.51±0.24 |
| Female | Ratio | 1.2 | 2.2 | 1.35±0.20 | 1.30±0.19 | 1.32±0.21 | 1.32±0.20 | 1.36±0.26 | 1.34±0.22 | |
| AST | Male | IU/L | 15 | 41 | 27.91±7.15 | 27.73±9.05 | 27.18±6.59 | 26.21±5.56 | 24.57±6.17 | 25.43±4.78 |
| Female | IU/L | 15 | 41 | 22.58±10.73 | 22.58±12.91 | 21.52±9.59 | 22.13±5.68 | 21.30±5.40 | 20.86±5.32 | |
| ALT | Male | IU/L | 10 | 40 | 38.55±14.98 | 37.18±19.36 | 37.18±18.41 | 26.57±9.10 | 24.50±8.46 | 25.50±7.38 |
| Female | IU/L | 10 | 40 | 22.04±9.65 | 21.25±9.44 | 20.78±9.10 | 20.43±8.52 | 20.26±7.34 | 20.33±9.38 | |
| ALK Phosphatase | Male | IU/L | 38 | 126 | 68.27±13.91 | 64.09±11.56 | 65.36±10.45 | 57.71±7.49 | 57.64±9.47 | 59.29±11.58 |
| Female | IU/L | 38 | 126 | 76.04±22.06 | 77.96±21.42 | 76.57±22.06 | 63.09±14.40 | 62.13±11.83 | 62.43±13.74 | |
| Total bilirubin | Male | IU/L | 0.3 | 1.2 | 1.05±0.55 | 1.11±0.53 | 0.99±0.71 | 0.87±0.20 | 0.91±0.26 | 0.86±0.27 |
| Female | IU/L | 0.3 | 1.2 | 0.75±0.21 | 0.81±0.23 | 0.80±0.31 | 0.79±0.33 | 0.75±0.39 | 0.77±0.23 | |
| Direct bilirubin | Male | mg/dL | 0 | 0.2 | 0.15±0.08 | 0.13±0.06 | 0.12±0.09 | 0.09±0.05 | 0.12±0.04 | 0.10±0.06 |
| Female | mg/dL | 0 | 0.2 | 0.11±0.04 | 0.09±0.07 | 0.10±0.05 | 0.08±0.05 | 0.10±0.10 | 0.08±0.06 | |
BUN, blood urea nitrogen; GFR, glomerular filtration rate.